PLEASANTON, Calif.,
Dec. 22, 2021 /PRNewswire/ -- 10x
Genomics, Inc. (Nasdaq: TXG) today announced the company will be
participating in the upcoming 40th Annual J.P. Morgan Healthcare
Conference.
10x Genomics' management is scheduled to present virtually on
Monday, January 10, at 2:15 p.m. Eastern Time / 11:15 a.m. Pacific Time. Interested parties
may access a live and archived webcast of the presentation on the
"Investors" section of the company's website at:
https://investors.10xgenomics.com/.
About 10x Genomics
10x Genomics is a life science technology company building
products to interrogate, understand and master biology to advance
human health. The company's integrated solutions include
instruments, consumables and software for analyzing biological
systems at a resolution and scale that matches the complexity of
biology. 10x Genomics products have been adopted by researchers
around the world including in all of the top 100 global research
institutions as ranked by Nature in 2020 based on publications and
all of the top 20 global pharmaceutical companies by 2020 research
and development spend, and have been cited in over 3,000 research
papers on discoveries ranging from oncology to immunology and
neuroscience. The company's patent portfolio comprises more than
1,200 issued patents and patent applications.
Disclosure Information
10x Genomics uses filings with the Securities and Exchange
Commission, its website (www.10xgenomics.com), press releases,
public conference calls, public webcasts and its social media
accounts as means of disclosing material non-public information and
for complying with its disclosure obligations under Regulation
FD.
Media Contact:
media@10xgenomics.com
Investor Relations
Contact:
investors@10xgenomics.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-present-virtually-at-the-40th-annual-jp-morgan-healthcare-conference-301450093.html
SOURCE 10x Genomics, Inc.